These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 8488377

  • 1. [Hypercalcemia as an emergency].
    Rosenmund A.
    Schweiz Med Wochenschr; 1993 Apr 17; 123(15):735-8. PubMed ID: 8488377
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hypercalcaemia. Management.
    Selby PC, Peacock M, Marshall DH.
    Br J Hosp Med; 1984 Mar 17; 31(3):186, 188, 190 passim. PubMed ID: 6324944
    [No Abstract] [Full Text] [Related]

  • 4. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S, Tisell LE, Lindstedt G, Lundberg PA.
    Surgery; 1991 Sep 17; 110(3):480-6. PubMed ID: 1845370
    [Abstract] [Full Text] [Related]

  • 5. Therapy of malignancy-associated hypercalcemia: 1983.
    Stewart AF.
    Am J Med; 1983 Mar 17; 74(3):475-80. PubMed ID: 6219580
    [Abstract] [Full Text] [Related]

  • 6. Current management of malignant hypercalcaemia.
    Stevenson JC.
    Drugs; 1988 Aug 17; 36(2):229-38. PubMed ID: 3053127
    [Abstract] [Full Text] [Related]

  • 7. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M, Takami H.
    Oncol Rep; 1998 Aug 17; 5(1):197-9. PubMed ID: 9458321
    [Abstract] [Full Text] [Related]

  • 8. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy.
    Kovacs CS, MacDonald SM, Chik CL, Bruera E.
    J Pain Symptom Manage; 1995 Apr 17; 10(3):224-32. PubMed ID: 7543127
    [Abstract] [Full Text] [Related]

  • 9. Conventional treatment of hypercalcemia of malignancy.
    Davidson TG.
    Am J Health Syst Pharm; 2001 Nov 15; 58 Suppl 3():S8-15. PubMed ID: 11757206
    [Abstract] [Full Text] [Related]

  • 10. [Combination therapy with pamidronate and calcitonin in hypercalcemic crisis caused by primary hyperparathyroidism].
    Christensen JH, Kristiansen JH.
    Ugeskr Laeger; 1992 Nov 16; 154(47):3341-2. PubMed ID: 1462441
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Hypercalcemia].
    Takemoto F.
    Nihon Rinsho; 2004 May 16; 62 Suppl 5():505-10. PubMed ID: 15197973
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA.
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec 16; 18(6):339-46. PubMed ID: 21897221
    [Abstract] [Full Text] [Related]

  • 17. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E.
    Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357
    [Abstract] [Full Text] [Related]

  • 18. Rapid Fire: Hypercalcemia.
    Carrick AI, Costner HB.
    Emerg Med Clin North Am; 2018 Aug 01; 36(3):549-555. PubMed ID: 30037441
    [Abstract] [Full Text] [Related]

  • 19. Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955.
    Blind E, Raue F, Meinel T, Wüster C, Ziegler R.
    Horm Metab Res; 1993 Jan 01; 25(1):40-4. PubMed ID: 8428711
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of malignancy-associated hypercalcemia].
    Endo I, Inoue D.
    Clin Calcium; 2006 Apr 01; 16(4):665-69. PubMed ID: 16582519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.